Dola, Samer

Dola, Samer was paid $5.82M by Medicaid between Jan 2018 and Dec 2024, across 178 billing codes. Its largest line is 87633, Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets — 9.2% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	61,722	$442K
2019	77,252	$532K
2020	73,893	$754K
2021	91,687	$971K
2022	116,416	$1.03M
2023	123,741	$901K
2024incomplete	207,771	$1.19M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	9.2%	3,211	2,863	$536K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	7.4%	5,776	5,321	$432K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	6.8%	16,623	14,120	$397K
80053	Comprehensive metabolic panel	6.6%	75,244	53,123	$386K
0202U	Oncology (prostate), multianalyte, gene expression profiling	6.1%	1,548	1,457	$358K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	6.0%	121,005	72,727	$350K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	5.2%	14,077	13,358	$304K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	4.2%	6,317	5,249	$245K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	3.7%	5,975	5,553	$214K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	2.8%	5,227	4,821	$165K
80048	Basic metabolic panel (calcium, ionized)	2.8%	39,467	22,111	$162K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	2.0%	3,182	2,829	$118K

166 more codes

82805		1.9%	4,657	$113K
84484		1.9%	20,749	$108K
83735		1.8%	31,722	$107K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	1.4%	4,182	$84K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	1.4%	4,149	$84K
84443	Thyroid stimulating hormone (TSH)	1.4%	10,042	$82K
83880		1.3%	6,877	$76K
87581		1.2%	3,223	$72K
87486		1.2%	3,208	$72K
87040		1.2%	6,870	$70K
87507		1.0%	393	$60K
83690		<1%	16,443	$55K
87631		<1%	1,100	$55K
81025		<1%	22,043	$50K
83605		<1%	7,862	$42K
87086	Culture, bacterial; quantitative colony count, urine	<1%	8,411	$40K
82550		<1%	14,580	$40K
81001		<1%	28,583	$39K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	988	$33K
80061	Lipid panel	<1%	8,521	$32K
85610		<1%	14,847	$29K
85730		<1%	8,504	$28K
87186		<1%	4,616	$27K
84702		<1%	5,814	$26K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	1,832	$26K
87088		<1%	4,631	$25K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	2,893	$23K
83036	Hemoglobin; glycosylated (A1C)	<1%	7,285	$23K
86850		<1%	7,618	$23K
82962		<1%	13,757	$22K
87797		<1%	1,633	$21K
84439		<1%	4,711	$20K
82607		<1%	3,414	$20K
84100		<1%	10,589	$20K
81003		<1%	18,580	$20K
86901		<1%	8,890	$19K
85379		<1%	4,997	$19K
80076		<1%	4,884	$17K
86900		<1%	9,853	$17K
87340		<1%	2,558	$16K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	823	$16K
84145		<1%	2,197	$15K
84703		<1%	4,086	$15K
86703		<1%	1,596	$14K
87070		<1%	4,079	$13K
85027		<1%	4,398	$12K
82728		<1%	3,024	$12K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	1,411	$11K
82746		<1%	1,925	$11K
82140		<1%	2,336	$10K
80202		<1%	1,536	$10K
82784		<1%	1,760	$10K
83540		<1%	2,966	$9K
82948		<1%	5,682	$9K
86592		<1%	4,575	$9K
87265		<1%	1,601	$9K
86140		<1%	3,900	$9K
85384		<1%	2,973	$9K
82247		<1%	3,422	$9K
83615		<1%	3,258	$8K
87081		<1%	2,896	$8K
86803		<1%	1,000	$8K
86701		<1%	1,311	$8K
87205		<1%	3,592	$7K
83550		<1%	1,741	$7K
84550		<1%	3,428	$7K
82248		<1%	3,100	$6K
86870		<1%	859	$6K
85651		<1%	2,603	$6K
82330		<1%	760	$6K
86780		<1%	726	$6K
86480		<1%	176	$5K
82077		<1%	350	$4K
83655		<1%	693	$4K
86704		<1%	535	$4K
87493		<1%	209	$4K
87641		<1%	215	$4K
86880		<1%	1,327	$4K
86762		<1%	872	$4K
87184		<1%	778	$4K
86038		<1%	475	$3K
83970		<1%	206	$3K
86709		<1%	916	$3K
82150		<1%	875	$3K
85018		<1%	2,440	$3K
87653		<1%	122	$3K
82565		<1%	1,190	$3K
82010		<1%	1,092	$2K
87650		<1%	190	$2K
87210		<1%	921	$2K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	82	$2K
85014		<1%	1,695	$2K
82947		<1%	1,198	$2K
84481		<1%	370	$2K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	114	$2K
82570		<1%	680	$2K
88307		<1%	28	$2K
87077		<1%	599	$2K
85378		<1%	422	$1K
82043		<1%	706	$1K
85045		<1%	1,048	$1K
83520		<1%	144	$1K
84132		<1%	624	$1K
80074		<1%	57	$1K
82274		<1%	188	$964.47
84436		<1%	286	$956.64
84466		<1%	216	$949.96
86308		<1%	395	$944.40
80164		<1%	162	$757.72
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	95	$745.75
87015		<1%	198	$743.60
82378		<1%	116	$738.10
87075		<1%	114	$691.54
84300		<1%	315	$670.64
84480		<1%	141	$660.38
89051		<1%	200	$657.50
87147		<1%	256	$614.40
85007		<1%	343	$578.94
87522	Neg quan hep c or qual rna	<1%	26	$574.06
86706		<1%	100	$559.95
86696		<1%	56	$533.10
83050		<1%	172	$487.11
82553		<1%	116	$441.99
87420		<1%	54	$416.05
82533		<1%	58	$402.60
86003		<1%	13	$400.92
84153		<1%	59	$366.96
86695		<1%	54	$350.50
83013		<1%	13	$291.13
84155		<1%	200	$287.06
80050	General health panel	<1%	962	$276.90
80177		<1%	57	$269.33
84402		<1%	25	$229.25
88304		<1%	12	$226.96
83986		<1%	117	$204.86
85652		<1%	154	$197.03
83930		<1%	72	$177.08
84156		<1%	136	$167.44
85046		<1%	63	$167.14
84146		<1%	24	$161.88
84295		<1%	75	$153.24
85303		<1%	27	$152.10
83519		<1%	23	$151.80
82435		<1%	77	$144.01
83516		<1%	15	$140.48
83001		<1%	15	$136.35
84133		<1%	64	$134.40
84478		<1%	93	$132.72
86705		<1%	21	$126.13
80185		<1%	18	$115.52
83935		<1%	48	$111.93
87209		<1%	14	$105.42
82009		<1%	87	$101.48
87341		<1%	19	$97.66
83002		<1%	13	$84.24
87449		<1%	13	$77.87
86376		<1%	17	$71.40
82375		<1%	17	$66.60
85660		<1%	16	$51.26
87177		<1%	14	$50.40
82436		<1%	17	$39.61
80178		<1%	12	$38.76
82950		<1%	14	$30.74
84157		<1%	19	$26.60
82945		<1%	16	$24.64
80377		0%	1,076	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.